| Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer D Cui Zhou, RG Jayasinghe, S Chen, JM Herndon, MD Iglesia, P Navale, ... Nature genetics 54 (9), 1390-1405, 2022 | 79 | 2022 |
| Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness Y Li, TSM Lih, SM Dhanasekaran, R Mannan, L Chen, M Cieslik, Y Wu, ... Cancer cell 41 (1), 139-163. e17, 2023 | 53 | 2023 |
| Anti-proliferative and anti-inflammatory activities of the sea cucumber Holothuria polii aqueous extract M Kareh, R El Nahas, L Al-Aaraj, S Al-Ghadban, N Naser Al Deen, ... SAGE open medicine 6, 2050312118809541, 2018 | 35 | 2018 |
| Connexin43 as a tumor suppressor: Proposed Connexin43 mRNA-circularRNAs-microRNAs axis towards prevention and early detection in breast cancer N Naser Al Deen, M AbouHaidar, R Talhouk Frontiers in medicine 6, 192, 2019 | 17 | 2019 |
| Cross-roads to drug resistance and metastasis in breast cancer: miRNAs regulatory function and biomarker capability N Naser Al Deen, F Nassar, R Nasr, R Talhouk Breast Cancer Metastasis and Drug Resistance: Challenges and Progress, 335-364, 2019 | 17 | 2019 |
| Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma Y Wu, NV Terekhanova, W Caravan, N Naser Al Deen, P Lal, S Chen, ... Nature Communications 14 (1), 1681, 2023 | 14 | 2023 |
| Spatial drivers and pre-cancer populations collaborate with the microenvironment in untreated and chemo-resistant pancreatic cancer DC Zhou, RG Jayasinghe, JM Herndon, E Storrs, CK Mo, Y Wu, RS Fulton, ... BioRxiv, 2021.01. 13.426413, 2021 | 13 | 2021 |
| Epigenetic regulation during cancer transitions across 11 tumour types NV Terekhanova, A Karpova, WW Liang, A Strzalkowski, S Chen, Y Li, ... Nature 623 (7986), 432-441, 2023 | 7 | 2023 |
| Biomimetic sulfated glycosaminoglycans maintain differentiation markers of breast epithelial cells and preferentially inhibit proliferation of cancer cells Z Habli, NN Al Deen, W Malaeb, N Mahfouz, A Mermerian, R Talhouk, ... Acta Biomaterialia 122, 186-198, 2021 | 5 | 2021 |
| A risk progression breast epithelial 3D culture model reveals Cx43/hsa_circ_0077755/miR-182 as a biomarker axis for heightened risk of breast cancer initiation N Naser Al Deen, N Atallah Lanman, S Chittiboyina, S Lelièvre, R Nasr, ... Scientific Reports 11 (1), 2626, 2021 | 5 | 2021 |
| Over-expression of miR-183-5p or miR-492 triggers invasion and proliferation and loss of polarity in non-neoplastic breast epithelium N Naser Al Deen, N Atallah Lanman, S Chittiboyina, S Fostok, R Nasr, ... Scientific Reports 12 (1), 21974, 2022 | 2 | 2022 |
| Endotoxin Triggers Tumor Initiation Events in Nontumorigenic Breast Epithelial Cells and Enhances Invasion-Related Phenotype in Pretumorigenic and Tumorigenic Breast Epithelial … 1 Farah Yassine ,1 Sabreen F. Fostok ,1 Nataly Naser Al Deen ,1 and Rabih S ... International Journal of Inflammation 2021 (https://doi.org/10.1155/2021 …, 2021 | 2 | 2021 |
| Comprehensive proteogenomic characterization of rare kidney tumors GX Li, Y Hsiao, L Chen, R Mannan, Y Zhang, F Petralia, H Cho, ... Cancer Research 83 (7_Supplement), 3127-3127, 2023 | 1 | 2023 |
| Biopsy analysis of trial S1616: Ipilimumab plus nivolumab versus ipilimumab alone in patients with anti-PD-1 refractory melanoma KM Campbell, Z Bustami, DG Chen, E Medina, CR Gonzalez, NN Aldeen, ... Cancer Research 84 (6_Supplement), 6550-6550, 2024 | | 2024 |
| CRISPR-Mediated knockout of Ceruloplasmin (CP) and UCHL1 reveals angiogenic role in renal cell carcinoma (RCC) cell survival and proliferation W Caravan, Y Wu, P Lal, K Sato, Y Li, NNA Deen, S Chen, A Abedin, ... Cancer Research 84 (6_Supplement), 5670-5670, 2024 | | 2024 |
| Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages MD Iglesia, RG Jayasinghe, S Chen, NV Terekhanova, JM Herndon, ... bioRxiv, 2023.10. 31.565031, 2023 | | 2023 |
| WU sn-prep Protocol for solid tumors-ATAC v2. 7 W Caravan, R Jayasinghe, NN Al Deen | | 2023 |
| WU sn-prep Protocol for solid tumors-joint snRNA+ ATAC v2. 9 R Jayasinghe, W Caravan, A Houston, NN Al Deen | | 2023 |
| Author Correction: Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma Y Wu, NV Terekhanova, W Caravan, N Naser Al Deen, P Lal, S Chen, ... Nature Communications 14 (1), 2817, 2023 | | 2023 |
| CD8 T cell-melanoma cell interactions in response and resistance to ipilimumab plus nivolumab: Biopsy analysis of SWOG S1616 KM Campbell, L Kuklinski, Z Bustami, J Maxey, E Medina, ... Cancer Research 83 (7_Supplement), 4527-4527, 2023 | | 2023 |
